Applied Cognition is developing a novel medical device and platform for translational measurement of a newly discovered biology of the brain whose failure has been shown to cause neurodegeneration in preclinical models. We will be the first to non-invasively, continuously measure this biology in humans enabling us to develop treatments that stop or reverse the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
